TY - JOUR T1 - Covid-19 Risk Among Airline Passengers: Should the Middle Seat Stay Empty? JF - medRxiv DO - 10.1101/2020.07.02.20143826 SP - 2020.07.02.20143826 AU - Arnold Barnett Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/08/02/2020.07.02.20143826.abstract N2 - We use recent data and research results to approximate the probability that an air traveler in coach will contract Covid-19 on a US domestic flight two hours long, both when all coach seats are full and when all but middle seats are full. The point estimates we reach based on data from late June 2020 are 1 in 4,300 for full flights and 1 in 7,700 when middle seats are kept empty. These estimates are subject to both quantifiable and nonquantifiable sources of uncertainty, and sustain known margins of error of a factor about 2.5. However, because uncertainties in key parameters affect both risk estimates the same way, they leave the relative risk ratio for “fill all seats” compared to “middle seat open” close to 1.8 (i.e., close to 1/4,300)/(1/7,700). We estimate the mortality risks caused by Covid-19 infections contracted on airplanes, taking into account that infected passengers can in turn infect others. The point estimates—which use 2019 data about the percentage of seats actually occupied on US flights--range from one death per 400,000 passengers to one death per 600,000. These death-risk levels are considerably higher than those associated with plane crashes but comparable to those arising from two hours of everyday activities during the pandemic.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNoneAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No such body has considered the work.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data are readily available in public sources, like new confirmed Covid-19 cases by day in US states. These sources are identified in the paper. ER -